ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jose M. Bernal
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernal, J. M.
Right arrow Articles by Revuelta, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernal, J. M.
Right arrow Articles by Revuelta, J. M.

Ann Thorac Surg 1992;54:152-154
© 1992 The Society of Thoracic Surgeons


Articles

Early structural deterioration with the mitroflow pericardial Xenograft in the mitral position

Jose M. Bernal, MD*, Jose M. Rabasa, MD, Jose R. Echevarria, MD, Jose M. Revuelta, MD

Cardiovascular Surgery, Hospital Universitario Valdecilla, Universidad de Cantabria, Santander, Spain

Accepted for publication October 15, 1991.

* Address reprint requests to Dr Bernal, Cirugia Cardiovascular, Hospital Universitario Valdecilla, 39008 Santander, Spain.

Early structural deterioration with the mitral Mitroflow pericardial valve requiring reoperation occurred in 6 patients. Clinical diagnosis of prosthetic failure was made 5 to 58 months after valve implantation (mean, 38 months). Re-replacement was carried out 22 to 80 months (mean, 55 months) after the initial operation. Mode of failures were cuspal tear without calcification in three valves and massive calcifications in the remaining bioprostheses. High incidence of early structural deterioration of the Mitroflow pericardial valve makes this new prosthesis an unsatisfactory alternative as a substitute in the mitral position.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. Butany, T. Feng, A. Luk, K. Law, R. Suri, and V. Nair
Modes of Failure in Explanted Mitroflow Pericardial Valves
Ann. Thorac. Surg., November 1, 2011; 92(5): 1621 - 1627.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
K. Athanassiadi, M. Gerazounis, E. Metaxas, and N. Kalantzi
Management of esophageal foreign bodies: a retrospective review of 400 cases
Eur J Cardiothorac Surg, April 1, 2002; 21(4): 653 - 656.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Yamada, H. Sato, M. Seki, S. Kitagawa, M. Nakagawa, and H. Shimazaki
Successful Salvage of Aortoesophageal Fistula Caused by a Fish Bone
Ann. Thorac. Surg., June 1, 1996; 61(6): 1843 - 1845.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. M. Bernal, J. M. Rabasa, R. Lopez, J. Francisco Nistal, R. Muniz, and J. M. Revuelta
Durability of the Carpentier-Edwards porcine bioprosthesis: Role of age and valve position
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S248 - S252.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. L. Pomar, W. R. Eric Jamieson, L. Conrad Pelletier, A. N. Gerein, M. Castella, and R. T. Brownlee
Mitroflow pericardial bioprosthesis: Clinical performance to ten years
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S305 - S310.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.